Main > ENDOCRINOLOGY > Diabetes Type II > Treatment > Co: UK. A. Dapagliflozin+Saxaglipt>

---

Co: UK. A. Dapagliflozin+Saxaglipt>'s subsections
(*) EU Approval Date: 2016. 07.19.
(*) USA Approval Date: 2017. 02.28.
>in
Company
TradeMark

Co: UK. A. Dapagliflozin+Saxaglipt>'s products
This section has no products